Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients.
Di Pietro, Natalia
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. [electronic resource] - Molecular and cellular biochemistry Jun 2016 - 155-67 p. digital
Publication Type: Journal Article
1573-4919
10.1007/s11010-016-2723-0 doi
Aged
Calmodulin--metabolism
Cyclic GMP--metabolism
Erythrocytes--metabolism
Female
HSP90 Heat-Shock Proteins--metabolism
Humans
Kidney Failure, Chronic--metabolism
Male
Middle Aged
Multidrug Resistance-Associated Proteins--biosynthesis
Nitric Oxide--biosynthesis
Nitric Oxide Synthase Type III--metabolism
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. [electronic resource] - Molecular and cellular biochemistry Jun 2016 - 155-67 p. digital
Publication Type: Journal Article
1573-4919
10.1007/s11010-016-2723-0 doi
Aged
Calmodulin--metabolism
Cyclic GMP--metabolism
Erythrocytes--metabolism
Female
HSP90 Heat-Shock Proteins--metabolism
Humans
Kidney Failure, Chronic--metabolism
Male
Middle Aged
Multidrug Resistance-Associated Proteins--biosynthesis
Nitric Oxide--biosynthesis
Nitric Oxide Synthase Type III--metabolism